What is Terazosin?
Terazosin is a selective alpha-1 adrenergic receptor blocking medication used to treat two conditions: high blood pressure (hypertension) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) in men. 1
Mechanism of Action
Terazosin works by relaxing smooth muscle through selective blockade of alpha-1 adrenergic receptors 1:
- For hypertension: It relaxes blood vessel walls, allowing blood to pass through more easily and lowering blood pressure
- For BPH: It relaxes the tightness of muscles in the prostate and at the bladder opening, which increases urine flow rate and decreases urinary symptoms
Chemical Properties
Terazosin hydrochloride is a quinazoline derivative that is structurally similar to prazosin but with important differences 1, 2:
- Water solubility: 25 times greater than prazosin
- Half-life: Approximately 12 hours—about 3-4 times longer than prazosin 2, 3
- This longer half-life allows once-daily dosing, which improves patient compliance
Clinical Uses
For Hypertension
Terazosin effectively lowers blood pressure in patients with mild-to-moderate essential hypertension 1, 2. It can be used alone or in combination with diuretics and other antihypertensive agents.
For BPH
Terazosin is NOT a first-line alpha blocker for BPH treatment 4. Current guidelines recommend uroselective alpha blockers (tamsulosin, alfuzosin, or silodosin) as preferred agents because older, non-uroselective alpha blockers like terazosin and doxazosin have higher rates of orthostatic hypotension and dizziness 4.
However, if patients are already well-controlled on terazosin without side effects, there is no reason to discontinue it and switch to uroselective agents 4.
Dosing and Administration
- Initial dose: 1 mg at bedtime 1
- Titration: Can be increased gradually based on response
- Typical maintenance: 2-10 mg once daily
- Onset of symptom relief for BPH: 2-4 weeks 1
Important Clinical Considerations
Advantages
- Once-daily dosing improves compliance 2, 3
- Favorable lipid profile effects: Unlike diuretics and beta-blockers, terazosin may reduce total cholesterol and LDL cholesterol while potentially increasing HDL cholesterol 3
Key Adverse Effects
The most significant limitation is cardiovascular side effects 4:
- Orthostatic hypotension (postural blood pressure drops)
- Dizziness
- Asthenia (weakness)
- Peripheral edema
These side effects occur more frequently than with uroselective alpha blockers, which is why terazosin is no longer preferred for BPH 4.
Critical Safety Warning
Patients should be counseled about first-dose syncope risk—take the first dose at bedtime and rise slowly from sitting or lying positions to minimize orthostatic hypotension 1.
Current Clinical Position
While terazosin remains FDA-approved and effective for both hypertension and BPH, modern practice has largely moved away from it as a first-line BPH treatment in favor of uroselective alpha blockers with better side effect profiles 4. For hypertension, other drug classes are typically preferred as first-line agents in contemporary guidelines.
The main scenario for continuing terazosin is in patients already stable on the medication without problematic side effects 4.